Apollo Doctors Successfully Perform India's First Robotic CRS with HIPEC for Peritoneal Surface Cancer
Chennai, May 9th, 2024 In a major medical breakthrough, surgical oncologists at Apollo Cancer Centre (ACC) has successfully performed India's first Robotic Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for a peritoneal surface cancer. This minimally invasive, robotic-assisted approach marks a paradigm shift in treating Pseudomyxoma Peritonei (PMP), an aggressive appendix cancer, offering patients with a new standard of care, enabling faster recovery and improved quality of life. (L to R) Ms. Sheelaketan, CEO, ACC Chennai; Dr Bapuji , Senior Consultant - Anaesthesiologist, ACC Chennai; Dr Usha Mehta, Surgical Oncologist, ACC Chennai; Dinesh Madhavan, President - Group Oncology and International, Apollo Hospitals Enterprises Ltd; Dr Ajit Pai, Senior Consultant in Surgical Oncology and Robotic Surgery, ACC Chennai; Harshad Reddy, Director - Operations, Group Oncology and International, Apollo Hospitals Enterprises Ltd Dr. Ajit Pai, Senior C...